We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Conduent
CNDT
$264M
| $5.06K | ﹤0.01% |
1,487
+429
| +41% | +$1.41K |
|
1802
Jack Henry & Associates
JKHY
$11.1B
| $5.02K | ﹤0.01% |
30
+6
| +25% | +$934 |
|
1803
KRONOS Worldwide
KRO
$989M
| $5.02K | ﹤0.01% |
575
+326
| +131% | +$2.87K |
|
1804
Integra LifeSciences
IART
$1.34B
| $5.02K | ﹤0.01% |
122
-158
| -56% | -$7.6K |
|
1805
SPS Commerce
SPSC
$2.64B
| $4.99K | ﹤0.01% |
26
| – | – |
|
1806
TechTarget
TTGT
$278M
| $4.98K | ﹤0.01% |
160
| – | – |
|
1807
Boise Cascade
BCC
$3.02B
| $4.97K | ﹤0.01% |
55
| – | – |
|
1808
Bally's
BALY
$658M
| $4.96K | ﹤0.01% |
319
| – | – |
|
1809
Forestar Group
FOR
$1.51B
| $4.96K | ﹤0.01% |
220
+19
| +9% | +$366 |
|
|
BRFS
1810
DELISTED
BRF SA
BRFS
| $4.95K | ﹤0.01% |
2,606
-1,356
| -34% | -$2.09K |
|
1811
Winnebago Industries
WGO
$909M
| $4.93K | ﹤0.01% |
74
| – | – |
|
1812
Cactus
WHD
$5.44B
| $4.91K | ﹤0.01% |
116
-52
| -31% | -$2.03K |
|
1813
iRhythm Holdings
IRTC
$4.2B
| $4.9K | ﹤0.01% |
47
-5
| -10% | -$600 |
|
|
ARI
1814
Apollo Commercial Real Estate
ARI
$885M
| $4.88K | ﹤0.01% |
431
+155
| +56% | +$1.56K |
|
1815
Ashland
ASH
$3.5B
| $4.87K | ﹤0.01% |
56
+18
| +47% | +$1.66K |
|
1816
ACI Worldwide
ACIW
$5.42B
| $4.87K | ﹤0.01% |
210
| – | – |
|
|
TGNA
1817
DELISTED
TEGNA Inc
TGNA
| $4.86K | ﹤0.01% |
299
-510
| -63% | -$8.31K |
|
|
ALTR
1818
DELISTED
Altair Engineering Inc
ALTR
| $4.85K | ﹤0.01% |
64
| – | – |
|
1819
Petrobras Class A
PBR.A
$103B
| $4.85K | ﹤0.01% |
392
| – | – |
|
1820
Pulmonx
LUNG
$87.6M
| $4.84K | ﹤0.01% |
369
| – | – |
|
1821
EXL Service
EXLS
$5.29B
| $4.83K | ﹤0.01% |
160
-80
| -33% | -$2.52K |
|
|
NPKI
1822
NPK International
NPKI
$1.14B
| $4.83K | ﹤0.01% |
923
+763
| +477% | +$3.16K |
|
1823
National Healthcare
NHC
$3.38B
| $4.82K | ﹤0.01% |
78
-136
| -64% | -$8.06K |
|
1824
Enovis
ENOV
$1.53B
| $4.81K | ﹤0.01% |
75
| – | – |
|
1825
John B. Sanfilippo & Son
JBSS
$972M
| $4.81K | ﹤0.01% |
41
| – | – |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.